Pay in 4 interest-free payments of $6.69 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
We are encouraged by the results of TRIUMPH-4, which highlight the powerful effect of retatrutide, a first-in-class triple agonist, on body weight, pain and physical function, said Kenneth Custer, executive vice president at Eli Lilly and president of Lilly Cardiometabolic Health, in a statement from the company
Ann Gastroenterol (2012) 25(1):3744
Elkind-Hirsch said the findings are encouraging, but more studies are needed to better establish long-term safety and efficacy of GLP-1 receptor agonists for women with PCOS
Fully understanding how GLP-1s work and realistic expectations for results requires a conversation with your primary care provider, not just a checkout cart
